Cardiac Rhythm Management Devices – Market Insights – Europe (Supplemental)

The European CRM device market will continue to experience modest growth through 2032, primarily due to increasing adoption of premium-priced devices such as leadless pacemakers and S-ICDs. However, revenue growth will be limited to some extent by ASP declines caused by increasing competition in the leadless pacemaker and S-ICD markets.

This Medtech 360 Report provides comprehensive data and analysis on the state of the European CRM device market from 2019 through 2032.

Table of contents